Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02509377
Other study ID # 24890
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date July 2015
Est. completion date May 2017

Study information

Verified date June 2017
Source St. Louis University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Inclusion and exclusion criteria for fetal repair of MMC was established by the Management of Myelomeningocele Study (MOMS Trial) and these criteria are the standard of care throughout the United States. These criteria state exclusion for hypertension and diabetes which are known co-morbidities for obesity. Investigators plan to expand one exclusion criteria for open fetal repair surgery. Currently, an exclusion factor is a maternal BMI of 35.0 and greater.Investigators will maintain all other inclusion and exclusion criteria (including excluding for hypertension and diabetes) with the exception of expanding the BMI to include mothers with a BMI of 35.0 to 40.0. Co-morbidities of the research group will be compared to the comorbidities of the mothers published in the MOMS trial.


Description:

The MOMS trial proved prenatal repair of myelomeningocele was an advantage over postnatal repair for the fetus/neonate/child and is the standard of care for maternal/fetal dyads who meet the inclusion exclusion criteria. Investigators plan to maintain all inclusion exclusion criteria for open fetal repair surgery of myelomeningocele with one exception, the expansion of the maternal BMI to 40.0. This population of mothers with a BMI of 35.0 to 40.0 have not been studied. The morbidities of these mothers will be compared to morbidities of mothers with a BMI less than or equal to 34.9 currently in the scientific literature.


Recruitment information / eligibility

Status Terminated
Enrollment 1
Est. completion date May 2017
Est. primary completion date May 2017
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- Maternal BMI 35.0 to 40.0

- No maternal documented co-morbidities

- Fetal MMC begins between thoracic 1 and sacral 1, on the spinal column.

- Evidence of fetal hindbrain herniation (hindbrain is being pulled down the spinal column).

- A gestational age is between 19 weeks 0 days and 26 weeks with evidence of placental membrane fusion.

- Documented normal fetal karyotype.

Exclusion Criteria:

- History of maternal alloimmunization problem

- Kell sensitization

- Risk of preterm birth

- History of spontaneous preterm birth

- Cervix <20mm in length

- Presence of cerclage

- Placental problem

- History of placental abruption

- Placental Previa

- Body-mass index of 40.1 or more

- Maternal contraindication to surgery

- Insulin-dependent pregestational diabetes

- Hypertension or preeclampsia

- HIV, hepatitis-B, or hepatitis-C positive

- Other medical condition of risk to mother

- Uterine problem

- Previous hysterotomy in the active uterine segment

- Severe fibroids

- Uterine malformation (bicornuate, arcuate, unicornuate, didelphys)

- No support person for periprocedural period

- Inadequate support at home for pregnancy

- Inadequate understanding of risks and benefits of fetal surgery

- Inability to comply with medical restrictions, follow up after fetal surgery

- Multiple gestation pregnancy (twins, triplets, etc.)

- A fetal anomaly unrelated to myelomeningocele (heart defect, lung lesions)

- Severe fetal kyphosis >30 degrees (curvature of the back)

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Open Fetal Repair of Myelomeningocele
Open Fetal Repair of Myelomeningocele when mothers BMI is elevated

Locations

Country Name City State
United States SSM Cardinal Glennon Fetal Care Institute Saint Louis Missouri

Sponsors (1)

Lead Sponsor Collaborator
St. Louis University

Country where clinical trial is conducted

United States, 

References & Publications (1)

Adzick NS, Thom EA, Spong CY, Brock JW 3rd, Burrows PK, Johnson MP, Howell LJ, Farrell JA, Dabrowiak ME, Sutton LN, Gupta N, Tulipan NB, D'Alton ME, Farmer DL; MOMS Investigators. A randomized trial of prenatal versus postnatal repair of myelomeningocele. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Co-morbidities in mothers having fetal MMC repair Measure the co-morbidity of mothers with a BMI of 35.0 to 40.0. Compare to published data in the MOMS trial. up to 40 weeks
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Completed NCT02408315 - Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE) Phase 3